LG Life Sciences (068870)

67,500 0 (0.00%)
Close KRW Disclaimer

068870 Financial Summary

For the nine months ended 30 September 2016, LG Life Sciences, Ltd revenues increased 23% to W385.38B. Net income applicable to common stockholders increased from W8.95B to W24.61B. Revenues reflect Veterinary Pharmaceutical Products segment increase of 24% to W335.28B, Precision Chemical Segment increase of 14% to W50.11B, Domestic segment increase of 35% to W234.29B, China segment increase from W12.43B to W32.95B.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
068870
Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
Total Revenue
Net Income
Title
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Total Revenue 135,046.79 130,526.77 119,809.54 136,190.42
Gross Profit 62,312.84 67,958.82 65,867.81 62,774.86
Operating Income 9,062.01 10,513.37 17,124.11 6,032.75
Net Income 5,492.01 7,384.49 12,097.81 2,447.46
Clear All
0Selected
Please try another search
068870
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Total Assets 845,983.86 785,269.83 746,131.44 706,980.33
Total Liabilities 565,305.55 510,407.38 477,629.71 449,539.22
Total Equity 280,678.31 274,862.45 268,501.73 257,441.11
Clear All
0Selected
Please try another search
068870
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 27.37%
Cash
Net Change in Cash
Title
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Cash From Operating Activities 82,799.87 57,788.86 29,596.66 53,629.77
Cash From Investing Activities -109,366.30 -68,002.12 -27,717.70 -91,141.40
Cash From Financing Activities 45,602.34 28,142.46 20,527.29 11,346.50
Net Change in Cash 18,439.16 17,850.31 22,290.72 -26,205.63
Clear All
0Selected
Please try another search

* In Millions of KRW (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles